Correlation Between Chugai Pharmaceutical and Astellas Pharma
Can any of the company-specific risk be diversified away by investing in both Chugai Pharmaceutical and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chugai Pharmaceutical and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chugai Pharmaceutical Co and Astellas Pharma, you can compare the effects of market volatilities on Chugai Pharmaceutical and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chugai Pharmaceutical with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chugai Pharmaceutical and Astellas Pharma.
Diversification Opportunities for Chugai Pharmaceutical and Astellas Pharma
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Chugai and Astellas is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Chugai Pharmaceutical Co and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and Chugai Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chugai Pharmaceutical Co are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of Chugai Pharmaceutical i.e., Chugai Pharmaceutical and Astellas Pharma go up and down completely randomly.
Pair Corralation between Chugai Pharmaceutical and Astellas Pharma
Assuming the 90 days horizon Chugai Pharmaceutical Co is expected to generate 0.66 times more return on investment than Astellas Pharma. However, Chugai Pharmaceutical Co is 1.52 times less risky than Astellas Pharma. It trades about 0.04 of its potential returns per unit of risk. Astellas Pharma is currently generating about -0.01 per unit of risk. If you would invest 1,752 in Chugai Pharmaceutical Co on August 27, 2024 and sell it today you would earn a total of 278.00 from holding Chugai Pharmaceutical Co or generate 15.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 89.92% |
| Values | Daily Returns |
Chugai Pharmaceutical Co vs. Astellas Pharma
Performance |
| Timeline |
| Chugai Pharmaceutical |
| Astellas Pharma |
Chugai Pharmaceutical and Astellas Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chugai Pharmaceutical and Astellas Pharma
The main advantage of trading using opposite Chugai Pharmaceutical and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chugai Pharmaceutical position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.| Chugai Pharmaceutical vs. Sanofi ADR | Chugai Pharmaceutical vs. Bristol Myers Squibb | Chugai Pharmaceutical vs. AstraZeneca PLC ADR | Chugai Pharmaceutical vs. Gilead Sciences |
| Astellas Pharma vs. Sanofi ADR | Astellas Pharma vs. Bristol Myers Squibb | Astellas Pharma vs. AstraZeneca PLC ADR | Astellas Pharma vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |